{"database": "lobbying", "table": "lobbying_activities", "rows": [[1700996, "2be467c6-a7e0-400c-9553-a3b74936f90a", "Q2", "THE INGRAM GROUP LLC", 400577737, "ELI LILLY AND COMPANY", 2015, "second_quarter", "PHA", "General issues related to the biopharmaceutical and pharmaceutical industries.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2015-07-16T22:16:35.703000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1700996"], "units": {}, "query_ms": 21.781546995043755, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}